Z, X., L, K., Y, Z., W, H., P, M., J, Z., & P, Y. (2025). FXR/SMAD3 Regulates SOX9 to Inhibit Hepatic Fibrosis in Biliary Atresia via Inhibiting Ferroptosis of Hepatic Stellate Cells. Applied biochemistry and biotechnology, 197(12), 7946. https://doi.org/10.1007/s12010-025-05396-w
Chicago Style (17th ed.) CitationZ, Xi, Kong L, Zhang Y, He W, Ma P, Zhen J, and Yan P. "FXR/SMAD3 Regulates SOX9 to Inhibit Hepatic Fibrosis in Biliary Atresia via Inhibiting Ferroptosis of Hepatic Stellate Cells." Applied Biochemistry and Biotechnology 197, no. 12 (2025): 7946. https://doi.org/10.1007/s12010-025-05396-w.
MLA (9th ed.) CitationZ, Xi, et al. "FXR/SMAD3 Regulates SOX9 to Inhibit Hepatic Fibrosis in Biliary Atresia via Inhibiting Ferroptosis of Hepatic Stellate Cells." Applied Biochemistry and Biotechnology, vol. 197, no. 12, 2025, p. 7946, https://doi.org/10.1007/s12010-025-05396-w.